Education And Debate Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7472.972 (Published 21 October 2004) Cite this as: BMJ 2004;329:972 Article Related content Metrics Responses Peer review Data supplement References w1 - w16, further details and figures showing the effect on drug prices Files in this Data Supplement: References w1 - w16 and further detailsFigures showing the effect on drug prices Related articles Editor's Choice Transparency and trust Published: 21 October 2004; BMJ 329 doi:10.1136/bmj.329.7472.0-g See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265 Cited by... Economic evaluation of mental health interventions: an introduction to cost-utility analysisAbstract Fulltext PDF The Social Value Of Vaccination Programs: Beyond Cost-EffectivenessAbstract Fulltext PDF Australia's 'Fourth Hurdle' Drug Review Comparing Costs And Benefits Holds Lessons For The United StatesAbstract Fulltext PDF Role of Budget Impact in Drug Reimbursement DecisionsAbstract Fulltext PDF The cost-effectiveness of drug-eluting stents: a systematic reviewAbstract Fulltext PDF
